Similar articles

• Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.

  Pesta M, Fichtl J, Kulda V, Topolcan O, Treska V. Pesta M, et al. Anticancer Res. 2013 May;33(5):2239-43. Anticancer Res. 2013. PMID: 23645782
• Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.

  Wharton RQ, Jonas SK, Glover C, Khan ZA, Klokouzas A, Quinn H, Henry M, Allen-Mersh TG. Wharton RQ, et al. Clin Cancer Res. 1999 Dec;5(12):4158-63. Clin Cancer Res. 1999. PMID: 10632355
• Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients.

  Douard R, Moutereau S, Serru V, Sales JP, Wind P, Cugnenc PH, Vaubourdolle M, Loric S. Douard R, et al. Clin Chem Lab Med. 2005;43(2):127-32. doi: 10.1515/CCLM.2005.021. Clin Chem Lab Med. 2005. PMID: 15843204
• Liquid Biopsies in Colorectal Cancer: Monitoring Genetic Heterogeneity.

  Gargalionis AN, Papavassiliou AG. Gargalionis AN, et al. Trends Cancer. 2017 Mar;3(3):166-168. doi: 10.1016/j.trecan.2017.01.003. Epub 2017 Jan 27. Trends Cancer. 2017. PMID: 28718430 Review.
• Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis.

  Kin C, Kidess E, Poultsides GA, Visser BC, Jeffrey SS. Kin C, et al. Expert Rev Mol Diagn. 2013 Jul;13(6):581-99. doi: 10.1586/14737159.2013.811896. Expert Rev Mol Diagn. 2013. PMID: 23895128 Review.